{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:06:50Z","timestamp":1788973610433,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"publisher","award":["UJ-25-DR-20102"],"award-info":[{"award-number":["UJ-25-DR-20102"]}],"id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110245","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:51:38Z","timestamp":1783918298000},"page":"110245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells"],"prefix":"10.1016","volume":"180","author":[{"given":"Nagy A.","family":"Morsy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham A.","family":"El-Shiekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad M.","family":"Ebrahium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladdin M.","family":"Srour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bioorg.2026.110245_bb0005","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","article-title":"Alzheimer\u2019s disease: exploring the landscape of cognitive decline","volume":"15","author":"Tenchov","year":"2024","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110245_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/0118715249293642240522054929","article-title":"Research on Alzheimer\u2019s disease (AD) involving the use of in vivo and in vitro models and mechanisms","volume":"25","author":"Sinha","year":"2025","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110245_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177520","article-title":"Exploring Alzheimer\u2019s disease treatment: established therapies and novel strategies for future care","volume":"998","author":"Soni","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110245_bb0020","series-title":"Global Status Report on the Public Health Response to Dementia","author":"World Health Organization","year":"2021"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110245_bb0025","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bioorg.2026.110245_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00521-016-2416-3","article-title":"Diagnosis of Alzheimer\u2019s disease using naive Bayesian classifier","volume":"29","author":"Bhagya","year":"2018","journal-title":"Neural Comput. & Applic."},{"key":"10.1016\/j.bioorg.2026.110245_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2019.03.005","article-title":"Gene-environment interactions in Alzheimer\u2019s disease: a potential path to precision medicine","volume":"199","author":"Eid","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110245_bb0040","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jalz.2019.06.3914","article-title":"The Alzheimer\u2019s disease exposome","volume":"15","author":"Finch","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2026.110245_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.intimp.2019.03.039","article-title":"Dysfunctional microglia:neuron interactions with significant female bias in a developmental gene x environment rodent model of Alzheimer\u2019s disease","volume":"71","author":"von der Embse","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110245_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.14283\/jpad.2018.35","article-title":"Clinical application of APOE in Alzheimer\u2019s prevention: a precision medicine approach","volume":"5","author":"Berkowitz","year":"2018","journal-title":"J. Prev Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110245_bb0055","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2026.110245_bb0060","article-title":"Selective coactivation of \u03b17- and \u03b14\u03b22-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction","volume":"296","author":"Rob erts","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110245_bb0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/138945012800398973","article-title":"\u03b17 nicotinic acetylcholine receptors in Alzheimer\u2019s disease: neuroprotective, neurotrophic or both?","volume":"13","author":"Hernandez","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2026.110245_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111785","article-title":"Search for new multi-target compounds against Alzheimer\u2019s disease among histamine H3 receptor ligands","volume":"185","author":"Bajda","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110245_bb0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/14756366.2018.1543288","article-title":"Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies","volume":"34","author":"Cavdar","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2026.110245_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer\u2019s disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110245_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110245_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease","volume":"64","author":"Grossberg","year":"2003","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.bioorg.2026.110245_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101318","article-title":"Therapy for Alzheimer\u2019s disease: missing targets and functional markers?","volume":"68","author":"Stoiljkovic","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110245_bb0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"issue":"24","key":"10.1016\/j.bioorg.2026.110245_bb0105","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.4155\/fmc-2023-0238","article-title":"Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation","volume":"15","author":"Omar","year":"2023","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110245_bb0110","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110245_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16210","article-title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\u2019s disease (review of technology appraisal no. 111): a systematic review and economic model","volume":"16","author":"Bond","year":"2012","journal-title":"Health Technol. Assess."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110245_bb0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ejps.2013.04.024","article-title":"1,4-substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-\u03b2 aggregation crossing the blood-brain barrier","volume":"49","author":"Prinz","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110245_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/acschemneuro.8b00517","article-title":"Classics in chemical neuroscience: donepezil","volume":"10","author":"James","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110245_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10010","article-title":"The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer\u2019s disease","volume":"10","author":"Loveman","year":"2006","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.bioorg.2026.110245_bb0135","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/molecules20022296","article-title":"A facile ionic liquid promoted synthesis, cholinesterase inhibitory activity and molecular modeling study of novel highly functionalized Spiropyrrolidines","volume":"20","author":"Almansour","year":"2015","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110245_bb0140","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.bmc.2014.01.002","article-title":"Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies","volume":"22","author":"Kia","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110245_bb0145","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1055\/s-0029-1216975","article-title":"Asymmetric syntheses of oxindole and indole spirocyclic alkaloid natural products","volume":"18","author":"Trost","year":"2009","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2026.110245_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bioorg.2018.10.030","article-title":"Synthesis and 2D-QSAR study of dispiropyrrolodinyl-oxindole based alkaloids as cholinesterase inhibitors","volume":"83","author":"Srour","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110245_bb0155","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"10\u221212","key":"10.1016\/j.bioorg.2026.110245_bb0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1089\/ars.2023.0245","article-title":"Alzheimer\u2019s disease: a review of pathology, current treatments, and the potential therapeutic effect of decreasing oxidative stress by combined vitamin D and l-cysteine supplementation","volume":"40","author":"Jain","year":"2024","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110245_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad356","article-title":"Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants","volume":"6","author":"Houldsworth","year":"2024","journal-title":"Brain Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110245_bb0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/antiox11020408","article-title":"Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: role of nanoparticle-based drug delivery systems in clinical translation","volume":"11","author":"Ashok","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"27","key":"10.1016\/j.bioorg.2026.110245_bb0175","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.2174\/138161206778343109","article-title":"Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation","volume":"12","author":"Wang","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2026.110245_bb0180","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110245_bb0185","article-title":"Rational design, synthesis and molecular docking of dispiropyrrolodinyl-oxindole-based alkaloids as anti-breast cancer agents with dual VEGFR-2 and cholinesterase inhibition","volume":"1271","author":"Srour","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110245_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105131","article-title":"3-Alkenyl-2-oxindoles: synthesis, antiproliferative and antiviral properties against SARS-CoV-2","volume":"114","author":"Girgis","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110245_bb0195","series-title":"Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists","author":"Copeland","year":"2005"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110245_bb0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"42","key":"10.1016\/j.bioorg.2026.110245_bb0205","first-page":"41141","article-title":"Crystal structure of soman-aged human butyrylcholinesterase in complex with the substrate analog butyrylthiocholine, enzyme catalysis and regulation","volume":"278","author":"Nicolet","year":"2003"},{"key":"10.1016\/j.bioorg.2026.110245_bb0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.indcrop.2016.10.007","article-title":"Bioactive metabolites involved in the antioxidant, anticancer and anticalpain activities of Ficus carica L., Ceratonia siliqua L. and Quercus ilex L. extracts","volume":"95","author":"Amessis-Ouchemoukh","year":"2017","journal-title":"Ind. Crop. Prod."},{"key":"10.1016\/j.bioorg.2026.110245_bb0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0308-8146(00)00324-1","article-title":"The hydrophilic and lipophilic contribution to total antioxidant activity","volume":"73","author":"Arnao","year":"2001","journal-title":"Food Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110245_bb0220","doi-asserted-by":"crossref","first-page":"715","DOI":"10.5897\/JMPR2013.5350","article-title":"DNA damage protecting activity and in vitro antioxidant potential of the methanol extract of cherry (Prunus avium L)","volume":"8","author":"Kutlu","year":"2014","journal-title":"J. Med. Plant Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110245_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-39534-z","article-title":"New benzimidazole-alkanesulfonate conjugates as cholinesterase inhibitors with in vitro and in silico validation","volume":"16","author":"Omar","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110245_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fnagi.2019.00206","article-title":"Synergistic effects of curcumin and piperine as potent acetylcholine and Amyloidogenic inhibitors with significant neuroprotective activity in SH-SY5Y cells via computational molecular modeling and in vitro assay","volume":"11","author":"Abdul Manap","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioorg.2026.110245_bb0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnut.2017.00003","article-title":"Neuroprotective effects of selected microbial-derived phenolic metabolites and aroma compounds from wine in human SH-SY5Y neuroblastoma cells and their putative mechanisms of action","volume":"4","author":"Esteban-Fern\u00e1ndez","year":"2017","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110245_bb0240","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11064-017-2463-x","article-title":"Neuroprotective effects of phenolic and carboxylic acids on oxidative stress-induced toxicity in human neuroblastoma SH-SY5Y cells","volume":"43","author":"Gay","year":"2018","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110245_bb0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12272-013-0188-1","article-title":"Four new compounds from the bulbs of Lycoris aurea with neuroprotective effects against CoCl\u2082 and H\u2082O\u2082-induced SH-SY5Y cell injuries","volume":"37","author":"Jin","year":"2014","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110245_bb0250","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1038\/s41598-025-89550-8","article-title":"In vivo and in silico studies on the potential role of garden cress oil in attenuating methotrexate-induced inflammation and apoptosis in liver","volume":"15","author":"Mabrouk","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110245_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5352","article-title":"In vitro wound healing properties, antioxidant activities, HPLC-ESI-MS\/MS profile and phytoconstituents of the stem aqueous methanolic extract of Dracaena reflexa lam","volume":"36","author":"Raslan","year":"2022","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.bioorg.2026.110245_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110245_bb0265","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110245_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260853","article-title":"Pharmacokinetics and drug-likeness of antidiabetic flavonoids: molecular docking and DFT study","volume":"16","author":"Bitew","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2026.110245_bb0275","doi-asserted-by":"crossref","first-page":"i352","DOI":"10.1093\/bioinformatics\/btaf259","article-title":"ADME-drug-likeness: enriching molecular foundation models via pharmacokinetics-guided multi-task learning for drug-likeness prediction","volume":"41","author":"Bang","year":"2025","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110245_bb0280","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4155\/tde.11.65","article-title":"Decreased blood-brain barrier expression of P-glycoprotein in Alzheimer\u2019s disease: impact on pathogenesis and brain access of therapeutic agents","volume":"2","author":"Nicolazzo","year":"2011","journal-title":"Ther. Deliv."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110245_bb0285","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cpt.2035","article-title":"Abundance of P-glycoprotein and other drug transporters at the human blood-brain barrier in Alzheimer\u2019s disease: a quantitative targeted proteomic study","volume":"109","author":"Storelli","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2026.110245_bb0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2020.01.012","article-title":"Donepezil, a cholinesterase inhibitor used in Alzheimer\u2019s disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice","volume":"124","author":"Spieler","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110245_bb0295","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/pharmaceutics16060758","article-title":"Enhancing the bioavailability of poorly soluble drugs","volume":"16","author":"Pinal","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:49:20Z","timestamp":1787676560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"alternative-id":["S0045206826007819"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110245","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110245"}}